Which hedge funds own LKFT? LAKEFRONT BIOTHERAPEUTICS NV, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in LKFT (LAKEFRONT BIOTHERAPEUTICS NV) in their Q2 2026 13F filings, worth $35.3m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 1 manager opened a new position this quarter: Marshall Wace.
6tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold LKFT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $12.2m | 407,800 | 29% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $8.1m | 269,814 | -19% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $5.4m | 181,090 | 68% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $5.9m | 197,844 | -8% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $2.6m | 88,343 | -29% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $971.3k | 32,399 | – | new |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Greenlight Capital | Q4 2023 | 0.4% |
How has hedge fund ownership of LKFT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $35.3m |
| Q1 2026 | 5 | $32.9m |
| Q4 2025 | 2 | $26.1m |
| Q3 2025 | 3 | $29.0m |
| Q2 2025 | 3 | $23.6m |
| Q1 2025 | 2 | $9.2m |
| Q4 2024 | 3 | $10.4m |
| Q3 2024 | 2 | $9.8m |
| Q2 2024 | 2 | $7.9m |
| Q1 2024 | 3 | $11.8m |
| Q4 2023 | 4 | $25.8m |
| Q3 2023 | 4 | $23.1m |
| Q2 2023 | 4 | $58.5m |
| Q1 2023 | 4 | $50.6m |
| Q4 2022 | 4 | $29.3m |
| Q3 2022 | 3 | $22.0m |
Counts every tracked manager that disclosed LKFT in that quarter's filing, including managers that have since stopped filing.